Evaluating efficacy of denosumab compared with zoledronic acid in symptomatic myeloma

Long term effects of myeloma treatment

Update on CASTOR trial: Daratumumab, bortezomib, and dexamethasone for relapsed or refractory myeloma

Caring for multiple myeloma carers

Impact of recurrent myeloma alterations on drug response

What is the biology behind immunotherapy for MM?

Carfilzomib, cyclophosphamide, and dexamethasone in newly diagnosed multiple myeloma

Is precision myeloma medicine more hype than reality?

Asia-Pacific approaches to myeloma trials

Denosumab vs zoledronic acid for bone disease in newly diagnosed multiple myeloma

Bone disease and management of myeloma complications

Monoclonal antibodies in multiple myeloma